"10.1371_journal.pone.0139485","plos one","2015-09-30T00:00:00Z","Xiao-Yang Zhou; Fa-Ming Zhu; Jian-Ping Li; Wei Mao; De-Mei Zhang; Meng-Li Liu; Ai-Lian Hei; Da-Peng Dai; Ping Jiang; Xiao-Yan Shan; Bo-Wei Zhang; Chuan-Fu Zhu; Jie Shen; Zhi-Hui Deng; Zheng-Lei Wang; Wei-Jian Yu; Qiang Chen; Yan-Hui Qiao; Xiang-Ming Zhu; Rong Lv; Guo-Ying Li; Guo-Liang Li; Heng-Cong Li; Xu Zhang; Bin Pei; Li-Xin Jiao; Gang Shen; Ying Liu; Zhi-Hui Feng; Yu-Ping Su; Zhao-Xia Xu; Wen-Ying Di; Yao-Qin Jiang; Hong-Lei Fu; Xiang-Jun Liu; Xiang Liu; Mei-Zhen Zhou; Dan Du; Qi Liu; Ying Han; Zhi-Xin Zhang; Jian-Ping Cai","The Key Laboratory of Geriatrics, Beijing hospital & Beijing Institute of Geriatrics, Ministry of Health, Beijing, China; Quality control laboratory, China Bone Marrow Program, Beijing, China; HLA Laboratory, Zhejiang Blood Center, Hangzhou, Zhejiang, China; HLA Laboratory, Liaoning Blood Center, Shenyang, Liaoning, China; HLA Laboratory, Chongqing Blood Center, Chongqing, China; HLA Laboratory, Taiyuan Red Cross Blood Center, Taiyuan, Shanxi, China; HLA Laboratory, Shaanxi Blood Center, Xian, Shaanxi, China; HLA Laboratory, Beijing Red Cross Blood Center, Beijing, China; HLA Laboratory, Henan Blood Center, Zhengzhou, Henan, China; HLA Laboratory, Shandong Blood Center, Jinan, Shandong; HLA Laboratory, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China; The Key Laboratory of Histocompatibility and Immunogenetics, Shenzhen Blood Center, Shenzhen, Guangdong, China; HLA Laboratory, Hebei Blood Center, Shijiazhuang, Hebei, China; HLA Laboratory, Dalian Red Cross Blood Center, Dalian, Liaoning, China; HLA Laboratory, Institute of Blood Transfusion, Chinese Academy of Medical Sciences & Peking Union Medical College, Chengdu, Sichuan, China; HLA Laboratory, Xinjiang Blood Center, Urumchi, Xinjiang, China; HLA Laboratory, Kunming Blood Center, Kunming, Yunnan, China; HLA Laboratory, Hefei Red Cross Blood Center, Hefei, Anhui, China; HLA Laboratory, Gansu Red Cross Blood Center, Lanzhou, Gansu, China; HLA Laboratory, Jiangxi Blood Center, Nanchang, Jiangxi, China; HLA Laboratory, Nanning Blood Center, Nanning, Guangxi, China; HLA Laboratory, Xiamen Blood Center, Xiamen, Fujian, China; HLA Laboratory, Changchun Blood Center, Changchun, Jilin, China; HLA Laboratory, Wuhan Blood Center, Wuhan, Hubei, China; HLA Laboratory, Harbin Red Cross Blood Center, Harbin, Heilongjiang, China; HLA Laboratory, Qingdao Blood Center, Qingdao, Shandong, China; HLA Laboratory, Yueyang Red Cross Blood Center, Yueyang, Hunan, China; HLA Laboratory, Changsha Blood Center, Changsha, Hunan, China; HLA Laboratory, Soochow Red Cross Blood Center, Suzhou, Jiangsu, China; HLA Laboratory, Shanghai Blood Center, Shanghai, China; HLA Laboratory, BFR Transplant Diagnostic Service Center, Beijing China; HLA Laboratory, CapitalBio Corporation, Beijing, China; HLA Laboratory, Beijing Genomics Institute, Shenzhen, Guangdong, China; Department of HLA Technology, China Bone Marrow Program, Beijing, China","Conceived and designed the experiments: JPC ZXZ XYZ. Performed the experiments: XYZ FMZ JPL WM DMZ MLL ALH DPD PJ XYS BWZ CFZ JS ZHD ZLW WJY QC YHQ XMZ RL GYL GLL HCL XZ BP LXJ GS YL ZHF YPS ZXX WYD YQJ XL MZZ HLF XJL DD QL YH. Analyzed the data: JPC ZXZ XYZ FMZ JPL WM DMZ MLL ALH DPD PJ XYS BWZ CFZ JS ZHD ZLW WJY QC YHQ XMZ RL GYL GLL HCL XZ BP LXJ GS YL ZHF YPS ZXX WYD YQJ XL MZZ HLF XJL DD QL YH ZXZ. Contributed reagents/materials/analysis tools: XYZ HLF XJL ZXZ JPC. Wrote the paper: XYZ JPC.","The authors have declared that no competing interests exist.","2015","09","Xiao-Yang Zhou","XYZ",42,FALSE,3,40,42,2,TRUE,TRUE,FALSE,0,NA,FALSE
